Is bupropion (Wellbutrin) contraindicated in patients with a history of seizure disorders?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bupropion is Contraindicated in Patients with Seizure Disorders

Bupropion is absolutely contraindicated in patients with a history of seizure disorders. 1 This contraindication is explicitly stated in the FDA drug label and supported by multiple clinical guidelines.

Evidence for Contraindication

The FDA label for bupropion clearly states that:

  • Bupropion hydrochloride extended-release tablets (XL) are contraindicated in patients with seizure disorder 1
  • The medication can cause seizures, with the risk being dose-related 1

The National Comprehensive Cancer Network (NCCN) guidelines for smoking cessation similarly state that "bupropion is contraindicated for patients with seizure risks" 2

Praxis Medical Insights also confirms that "bupropion is contraindicated in patients with a history of seizure disorders" 3

Mechanism and Risk

Bupropion lowers the seizure threshold through its effects on the central nervous system. The risk of seizures with bupropion is dose-dependent:

  • At therapeutic doses up to 300 mg per day, the seizure incidence is approximately 0.1% (1/1000 patients) 1
  • The estimated seizure incidence increases almost tenfold between 450 and 600 mg/day 1
  • Even in patients without predisposition to seizures, the seizure risk exists 4

Risk Factors That Further Increase Seizure Risk

Several factors can further increase the risk of seizures with bupropion:

  • Concomitant use of medications that lower seizure threshold (antipsychotics, tricyclic antidepressants, theophylline, systemic corticosteroids) 1
  • Metabolic disorders (hypoglycemia, hyponatremia, severe hepatic impairment, hypoxia) 1
  • Use of illicit drugs or abuse of prescription drugs 1
  • Abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs 1

Clinical Cases Supporting Contraindication

Case reports document seizures occurring in patients taking bupropion:

  • A 66-year-old female with no personal or family history of seizures developed new-onset seizures 4 days after starting bupropion for smoking cessation 5
  • Multiple patients have experienced generalized tonic-clonic seizures after taking bupropion, even without personal or family seizure history 6

Alternative Medications for Patients with Seizure Disorders

For patients with seizure disorders requiring treatment for depression or smoking cessation:

  • SSRIs (sertraline, escitalopram, fluoxetine) are preferred for patients with anxiety disorders 3
  • SNRIs (duloxetine, venlafaxine) may be considered as alternatives 3
  • Nicotine replacement therapy is a safer option for smoking cessation in patients with seizure disorders 2

Monitoring and Management

If bupropion must be used in patients without seizure disorders but with other risk factors:

  • The dose should not exceed 300 mg once daily 1
  • Increase the dose gradually 1
  • Discontinue bupropion immediately and do not restart if the patient experiences a seizure 1
  • More frequent follow-up during dose titration is required 3
  • Patient and family education about seizure warning signs is essential 3

In conclusion, the evidence is clear and consistent across multiple authoritative sources: bupropion is contraindicated in patients with a history of seizure disorders due to its established risk of lowering the seizure threshold and precipitating seizures.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Generalized Anxiety Disorder and Depression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Bupropion-induced epileptic seizures].

Revue neurologique, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.